Aditya Bardia

Aditya Bardia, MD, MPH, FASCO

Associate Professor

Medicine

Harvard Medical School

Boston, Massachusetts, United States of America

Program Director, Breast Medical Oncology
Assistant Chief (Translational Research), Division of Hematology-Oncology
Professor of Medicine, Geffen School of Medicine, University of California Los Angeles
Director of Translational Research Integration, UCLA Health Jonsson Comprehensive Cancer Center

Explore Activities by Aditya Bardia

Title
Format
Credit Type
Credits
Integrating the Evidence on Adjuvant Therapy for High-risk HR-Positive/HER2-Negative Early Breast Cancer

Content Format:

Slideset

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

0.50
Integrating the Evidence on Adjuvant Therapy for High-risk HR-Positive/HER2-Negative Early Breast Cancer

Content Format:

Text Module

Credit Type:

AAPA | ABIM MOC | ACPE | AMA | ANCC

Credits:

0.50
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs

Content Format:

Podcast Episodes

Credit Type:

ABIM MOC | AMA

Credits:

0.75
Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.50
Steps Toward Precision Oncology: Role of SERD in Attacking Endocrine Resistance in HR+/HER2- Breast Cancer

Content Format:

Slideset

Credit Type:

ABIM MOC | AMA

Credits:

0.75
Targeting TROP-2 in Breast Cancer: How Experts Are Integrating TROP-2 ADCs Into Clinical Practice

Content Format:

Slideset

Credit Type:

--

Credits:

--
FAQs: The Expanding Role of Antibody–Drug Conjugates in Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Optimizing Integration of Precision Therapy Into the Treatment of HER2-Low, HR-Positive, and Triple Negative Breast Cancer: A Focus on HER2 Targeted and TROP-2–Targeted Therapy

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
Incorporating TROP-2–Targeted Therapies Into the Breast Cancer Landscape

Content Format:

Slideset

Credit Type:

--

Credits:

--
Therapeutic Strategies for HER2-Positive Breast Cancer: Exploring Clinical Trial Data and a Treatment Sequence Algorithm

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.00
Therapeutic Strategies for HER2-Positive Breast Cancer Today: Frequently Asked Questions

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
ExpressPointsTherapeutic Strategies for HER2-Positive Breast Cancer: Exploring Clinical Trial Data and a Treatment Sequence Algorithm

Content Format:

Slideset

Credit Type:

--

Credits:

--
Overview of HER2 and Treatment of HER2-Positive Early Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Treatment Selection in HER2-Positive Metastatic Breast Cancer

Content Format:

Slideset

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: HER2-Positive Metastatic Breast Cancer Expert Guidance

Content Format:

Tool

Credit Type:

--

Credits:

--
Update on ADCs and Biomarkers in Breast, Gastrointestinal, and Lung Cancers

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
HER2, HER3, and TROP2: An Update on Novel Treatments for Key Targets

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
How We Are Integrating New Findings Into Treatment for HER2-Positive Breast Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Smarter. Stronger. Together: Achieving Quality HER2-Positive Breast Cancer Care by Educating Providers and Patients

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.50
Mastering the Evolving Treatment Landscape in HER2-Positive Breast Cancer: Current Guidance and Future Perspectives

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Targeting HER2, TROP2 and HER3: Spotlight on Breast Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Express PointsSmarter. Stronger. Together: Achieving Quality HER2-Positive Breast Cancer Care by Educating Providers and Patients

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Mastering the Evolving Treatment Landscape in HER2-Positive Breast Cancer: Current Guidance and Future Perspectives

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00